BNET Industries
Johnson & Johnson (JNJ) is in the Pharma Industry
- Revenue
- Dec 30 2007
- $61.0B
- Profit
- Dec 30 2007
- $10.5B
- Market Cap
- May 14 2008
- $188.2B
Latest News and Analysis
Drugmakers Need to Rein in Ads, Hearing Told
By Susan Heavey WASHINGTON (Reuters) - Pharmaceutical companies need to be more responsible in touting products to consumers or else face tighter controls from Congress, a top U.S. Democratic lawmaker said on Thursday. Rep. Bart Stupak, at a hearing to discuss specific ads...
P&G Sues J&J Over Tooth-whitening Strip Patent
LOS ANGELES (Reuters) - Procter & Gamble Co PG said on Friday it sued Johnson & Johnson JNJ, claiming that J&J's Listerine Whitening Quick Dissolving Strips violate P&G patents. The lawsuit, filed on Friday in the U.S. District Court for the...
Drugmakers Win Appeal Over Alzheimer Curbs
By Ben Hirschler LONDON (Reuters UK) - An appeals court on Thursday ruled the country's healthcare cost-effectiveness watchdog had acted unfairly in the way it decided to curb access to Alzheimer's drugs, in a victory for drugmakers and patients. The move will let manufacturers renew their...
Wyeth Profit Hurt By Generics
NEW YORK (Reuters) - Wyeth WYE posted slightly lower first-quarter earnings on Tuesday, hurt by the recent launch of generic forms of its Protonix ulcer drug, but surprisingly strong sales of other medicines enabled the company to beat Wall Street profit...
Costs Help Merck and Novartis, Hit Lilly
By Bill Berkrot NEW YORK (Reuters) - Tight cost controls helped Merck & Co MRK and Swiss drugmaker Novartis AG NOVN to better-than-expected quarterly earnings on Monday, while high expenses contributed to disappointing results from Eli Lilly and Co LLY. Lilly...
Abbott Profit Up on Drugs Sales
By Ransdell Pierson NEW YORK (Reuters) - Abbott Laboratories Inc ABT said on Wednesday first-quarter earnings increased 34 percent on higher sales of its prescription drugs and medical devices and favorable foreign exchange factors. The company reported strong sales gains for its top...
J&J Profits Beat Estimates
By Ransdell Pierson NEW YORK (Reuters) - Johnson & Johnson JNJ posted better-than-expected quarterly earnings on Tuesday as the weak dollar and cost cutting offset plunging sales of anemia drugs hit by safety concerns and medicines facing generic competition. Demand for...
Corporate Blogs That Build Buzz
Will this be the year that you start a corporate blog? Or are you already knee-deep in the blogosphere and looking for new ideas? Completing our review of PRWeek's nice summation of the year just past in their 2007 Book of Lists, here are their "5 corporate...
One Brand, Many Markets: How to Create Powerful, Global Brands
If you dream big, you want your product to go global. But markets differ, and people's notions of everything from what's cool to what's cheap vary from South Africa to Sydney to San Francisco. So how much should you bend your brand to accommodate these local tastes? And if your...
Coping With Loads Of To-Do's
The author believes that stress is the root of many illnesses. He also thinks that massage therapy should not be considered a special treat, but preventative health care. Moreover, he subscribe to the ideas of taking micro breaks (one minute of stretching in an hour really does do the body...
Emotional Competence and Leadership Excellence at Johnson & Johnson: The Emotional Intelligence and Leadership Study
This paper describes that emotional competence differentiates successful leaders. High performing managers at the Johnson & Johnson Consumer and Personal Care Group were seen to possess significantly higher levels of Self-Awareness, Self-Management capability, Social Skills, and Organizational Savvy, all considered part of the Emotional Intelligence domain. This paper describes the...
Black & White
In fall 1982, Johnson & Johnson faced a crisis when seven people from the Midwest died after ingesting cyanide-laced Tylenol capsules. News of the murders traveled quickly and caused nationwide panic. And although Johnson & Johnson was certain the tampering had not taken place at its plants, the company was...
Johnson & Johnson ASP Building Case Study
The article describes about energy systems. This California Building Energy Initiative CBEI Program case study features the Advanced Sterilization Products' Johnson & Johnson office building at 33 Technology Drive in Irvine, California. It is a two-story structure encompassing 76,000 square feet of conditioned space, and was built in 1985. Energy...
Cordis Corporation
This case study describes about solar systems deployed by Johnson & Johnson. Johnson & Johnson, pleased with the performance of its solar systems at Neutrogena in California and PSGA/Ortho-McNeil Pharmaceuticals in Pennsylvania, decided to deploy a new solar electric system at the Cordis facility. Cordis Corporation, the world's leading developer...
Janssen Pharmaceutica Products, L.P.: A Johnson & Johnson Company
Janssen Pharmaceutica is a Johnson & Johnson company driven by dedication to product innovation, customer focus and employee and organization excellence. Since 1992, Janssen has been an active member of the Titusville community. As a socially responsible corporate citizen, Janssen is committed to protecting and improving the environment in communities...
Neutrogena Corporation, Los Angeles, California: A Johnson & Johnson Company
Neutrogena Corporation, a worldwide leader in premium skin, hair and cosmetic products, and a member of the Johnson & Johnson family of companies, is headquartered in Los Angeles, California. As California's energy situation becomes increasingly complicated, alternative measures are continually being sought to alleviate peak demand power shortages and to...
Process Excellence in the Manufacturing Value Chain
The pharmaceutical industry is facing serious challenges today to maintain revenues, margins and compliance in a more competitive global environment. Johnson & Johnson's response to these challenges was to establish a corporate "Process Excellence" program several years ago. Six Sigma addresses the need to reduce variability, Lean attempts to reduce...
Additional Resources
Partners Airspan Networks and Stutler Technologies Announce Early Success in New WiMAX Band
Airspan Networks Inc. (NASDAQ: AIRN), aleading worldwide provider of WiMAX-based broadband wireless accessnetworks, and Stutler Technologies, one of the nation's largest systemintegrators for wireless carriers, today highlighted successes in therecently allocated 3.65 GHz band in the United States. This band has beenmade available to supplement national licensed bands like 2.5...
JJ, handler named Officers of Year
An officer who stopped a man on a rampage in Pioneer Park, a resident who confronted a man who had just shot and killed a Corrections officer, and the most celebrated K9 in Utah history were just a few of the heroes honored by Salt Lake police Tuesday. ...
Wall Street News Alert: Breaking News Alert - OCOL! May 6, 2008
Wall Street News Alert's "stocks to watch" thismorning are: Oncolin Therapeutics (OTCBB: OCOL), Discovery Laboratories,Inc. (NASDAQ: DSCO), Pfizer Inc. (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ). There is more important news coming from Oncolin Therapeutics (OTCBB: OCOL), and the company should have investors monitoring the stock thismorning. Yesterday after...
- Next »
- page 1 of 472
- « Previous
Sort byClose
- Incorporated: 1887
- CEO: Mr. William C. Weldon
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the health care field. As of Dec 31 2007, Co. operated through three segments. Co.'s Consumer segment includes a range of products used in the baby and child care, skin care, oral and wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products. Co.'s Pharmaceutical segment includes a range of products used in therapeutics areas. Co.'s Medical Devices and Diagnostics segment includes a range of products used primarily in the professional fields by physicians, nurses, therapists, hospitals, diagnostic laboratories and clinics.
Key Competitors
Johnson & Johnson Company Info
Board of Directors
Mr. William C. Weldon
Chairman
Mr. Charles Prince
Dr. David Satcher Ph.D.
Ms. Christine A. Poon
Vice-Chairman
Dr. Mary Sue Coleman
Mr. James G. Cullen
Dr. Michael M. E. Johns M.D.
Mr. Arnold G. Langbo
Dr. Susan L. Lindquist
Mr. Leo F. Mullin
Mr. William D. Perez
Contact Information
One Johnson & Johnson Plaza
New Brunswick, NJ
732 524 0400